What Age Does NAD+ Start to Decline? What the Research Actually Shows
If you've searched what age does NAD+ decline, you've probably landed on a graphic claiming levels crash by up to 50% before you turn 40 and fall to single digits by your 60s. Those figures get repeated across wellness blogs and supplement marketing often enough that they read as settled fact. The actual peer-reviewed research is messier, and more interesting: NAD+ does appear to fall with age in several human studies, but how much, how fast, and even whether it happens at all depends heavily on which tissue you measure, who you measure it in, and how active they are.
The Claim You'll See Everywhere: “NAD+ Drops 50% by 40”
Search for NAD+ decline by age and you'll consistently find the same set of figures: NAD+ supposedly peaks in your early-to-mid 20s, falls by 40–50% by age 50, and can drop to as little as 1–10% of youthful levels by your 60s or 70s, leaving most midlife adults below a so-called ‘optimal range’ of 40–100 micromolar. These numbers circulate widely on commercial NAD+ testing and supplement sites, and they aren't invented from nothing — early animal studies and some human tissue research did find steep age-related drops. But the specific percentages rarely trace back to a single, well-controlled human study, and the more rigorous research published in recent years tells a considerably more cautious story.
What Age Does NAD+ Decline? What the Research Actually Found
A 2022 study in Frontiers in Endocrinology measured whole blood NAD+ in more than 1,500 healthy adults in China and found a decline that was only statistically significant in men aged 40–49, a pattern that flattened out again after age 50; women in the same cohort showed no consistent age-related trend at all. Separately, an analysis of human skin tissue spanning newborns to age 77, published in PLOS ONE, did find a strong inverse relationship between age and NAD+, though the decline tracked closely with rising activity of PARP, an NAD+-consuming enzyme, rather than following one fixed, universal timeline. Perhaps most strikingly, a Finnish cohort study of 237 adults aged 18 to 70 found that blood NAD+ didn't significantly decline with normal, healthy ageing at all — while a smaller muscle-tissue sample from the same group did show an age-related drop, even in healthy volunteers. Taken together, these studies point to a broad conclusion: age-related NAD+ decline appears to be real in several tissues, but it's neither as dramatic nor as uniform as the ‘50% by 40’ framing suggests.
Why Blood, Muscle and Skin Tell Different Stories
Part of the confusion comes down to what's actually being measured. Blood NAD+ is the easiest to sample and forms the basis of most commercial NAD+ level tests, but it doesn't necessarily mirror what's happening inside muscle, skin or brain tissue, each of which has its own turnover rate and its own exposure to the processes that consume NAD+. Sex also appears to matter: several studies, including the Chinese cohort above, found a meaningful age-related decline in men but a flatter, more variable pattern in women. Genetics, body composition and physical activity level all seem to play a role too — researchers behind the Finnish study speculated that their unusually active study population may partly explain why their results looked so different from earlier work. In short, there's unlikely to be one ‘correct’ age at which NAD+ starts dropping for everyone. It looks more like a trend shaped by tissue type, sex and lifestyle than a single birthday.
What's Actually Driving the Decline
Where the science is more settled is on mechanism, even if the exact timeline stays fuzzy. As cells accumulate stress over the years, certain NAD+-consuming enzymes, particularly CD38 and PARP, become more active and compete with the enzymes your cells rely on for energy production and repair for the same limited NAD+ supply. Research published in Cell Metabolism identified CD38 as a key driver of age-related NAD+ decline, and later work in Nature Metabolism linked rising CD38 activity to senescent cells accumulating in ageing tissue. This ‘rising consumption’ model is one reason some researchers think the story isn't really about age in isolation — it's about how much cellular stress has built up, which tends to track with age without being identical to it.
None of this pins down a precise age at which your own NAD+ levels start to fall — that isn't something research can determine for an individual. If you're curious whether you might personally be affected, our piece on 7 signs of low NAD+ levels covers commonly reported indicators, and if you're weighing whether restoring NAD+ levels affects the visible signs of ageing specifically, we've examined that question, and its limits, in does NAD+ reverse ageing?
Frequently Asked Questions
Is it true that NAD+ levels drop by 50% by age 40?
That figure is widely repeated in commercial NAD+ marketing, but it doesn't trace back to a single well-controlled human study. The peer-reviewed research is more mixed: some studies find modest, tissue-specific declines around midlife, while others, including a large Finnish cohort, found no significant drop in blood NAD+ with normal healthy ageing at all. It's best treated as a popular estimate rather than an established fact.
Does NAD+ decline the same way in men and women?
Not consistently. Several studies, including a 2022 analysis of over 1,500 adults, found a modest age-related decline in men that wasn't seen in women, whose NAD+ levels tended to fluctuate rather than trend steadily downward after age 50. Researchers haven't fully explained why sex affects the pattern, though hormonal and body-composition differences are thought to play a role.
Can lifestyle factors influence how NAD+ changes with age?
Some research suggests they might. A Finnish study of a notably physically active population found no significant blood NAD+ decline with normal ageing, and the researchers speculated that regular exercise could help preserve levels that might otherwise fall in a more sedentary population. This is an association rather than proven cause and effect, but it fits with what's understood about how activity affects cellular energy metabolism more broadly.
What is CD38 and why does it come up in NAD+ research?
CD38 is an enzyme that consumes NAD+ as part of normal cellular signalling, and its activity tends to increase as cells accumulate age-related stress. Research published in Cell Metabolism identified CD38 as a significant driver of age-related NAD+ decline, and later studies linked rising CD38 activity to senescent, or ‘ageing’, cells building up in tissue over time. It's one of the clearer mechanistic explanations for why NAD+ availability can fall even without a dramatic drop in production.
Is there a specific age when people should start thinking about NAD+ support?
There's no research-backed age threshold, and the evidence doesn't support treating any single birthday as a turning point. Because decline appears to be tissue-specific, sex-influenced and shaped by individual lifestyle factors, it's more useful to think about long-term wellness broadly than to tie NAD+ support to a strict age cutoff. Speak with a healthcare professional if you're considering starting any new supplement or injectable therapy.
This article is for general informational purposes only and does not constitute medical advice. Always speak with a qualified healthcare professional before starting any new supplement or injectable therapy.
Comments